Advocacy Cannabinoids Chronic Pain Patients 
Veriheal
FEBRUARY 21, 2023
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?
Cannabis Law Report
NOVEMBER 2, 2021
NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 23, 2021
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Patient-reported outcomes. PROGRAMME.and.ABSTRACTS.
NORML
FEBRUARY 13, 2019
Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.
MMJ Recs
MARCH 6, 2024
Despite this, pockets of advocacy and research persisted, leading to the gradual recognition of its therapeutic potential and subsequent legalization for medical use in various states starting in the late 20th century. Moreover, its use in palliative care has shown promising results in improving quality of life for terminally ill patients.
MMJ Recs
DECEMBER 22, 2023
Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana.
CannaMD
SEPTEMBER 9, 2019
He is a board member of the advocacy group Doctors For Cannabis Regulation and spent two years as an Associate Director of the Massachusetts Physician Health Service helping physicians with addiction and mental health issues. The same study noted that of those patients surveyed, 85.5% Marijuana and Pain Relief.
Expert insights. Personalized for you.
98 
Let's personalize your content